13125-57-0

2-Azido-1,3,5-tribromobenzene

Acetic acid,[2-bromo-4-[3-(1,2-dihydro-4-hydroxy-6-methyl-2-oxo-3-pyridinyl)-3-oxo-1-propenyl]phenoxy]-, methyl ester

Benzamide,3-[3-(1,2-dihydro-4-hydroxy-6-methyl-2-oxo-3-pyridinyl)-3-oxo-1-propenyl]-N-(2-methoxyethyl)-

1-Bromo-4-[(trans,trans)-4'-ethyl[1,1'-bicyclohexyl]-4-yl]benzene

1H-Purine-2,6,8(3H)-trione, tetrahydro-1,3-dimethyl-

Hexanoic acid,6-[5-chloro-2-[methyl[4-[[2-(phenylmethyl)benzoyl]amino]benzoyl]amino]phenoxy]-

6H-Pyrrolo[3,2-d]thiazole-5-carboxylic acid, 2-methyl-, ethyl ester

7H-Pyrrolo[2,3-d]pyrimidine-2-carbonitrile,6-[[4-[(diethylamino)methyl]phenyl]methyl]-7-(2,2-dimethylpropyl)-

1-Naphthalenesulfonic acid , 6-diazo-5,6-dihydro-5-oxo-,

2,4-Hexadienedioic acid, 3-sulfo-

SulfoniuM, ethylhexadecyl(2-oxo-2-phenylethyl)-, (OC-6-11)-hexafluoroantiMonate(1-) (9CI)

3-Azabicyclo[3.2.1]octan-8-amine, 3-(phenylmethyl)-

Piperazine,1-[[5-(5-ethyl-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)-2-thienyl]carbonyl]-4-(phenylmethyl)-

5H-1,4-Diazepin-5-one, 7-butylhexahydro

Alanine, 2-methyl-N-(methylsulfonyl)-

2(1H)-Pyridinone,3-[3-[3-[2-(dimethylamino)ethoxy]phenyl]-1-oxo-2-propenyl]-4-hydroxy-6-methyl-

1H-Inden-1-one, 2-[(ethylamino)methylene]-2,3-dihydro-

4,11-dimethyl-1a,2,3,11b-tetrahydrotetrapheno[8,9-b]oxirene-2,3-diol

2(1H)-Pyridinone,3-[3-[3-(2-aminoethoxy)phenyl]-1-oxo-2-propenyl]-4-hydroxy-1,6-dimethyl-

Acetonitrile,[3-[3-(1,2-dihydro-4-hydroxy-6-methyl-2-oxo-3-pyridinyl)-3-oxo-1-propenyl]phenoxy]-

thiophene-2-carbothioamide

7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-[(3-fluorophenyl)methyl]-

Dexpanthenol impurity F

1H-Pyrazole, 4-chloro-3-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]-

1-biphenyl-3-yl-4-bromo-1H-imidazole

1,3-Dioxane-2-propanethioamide, N-(phenylmethyl)-

4-Pyrimidinamine, 5-(4-bromophenyl)-2,6-dimethyl-

2-Thiophenecarboxamide,5-(5-ethyl-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)-N-(2-pyridinylmethyl)-

Piperazine,1-[4-chloro-3-(formylamino)phenyl]-4-[[4-chloro-5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-

Cyclopentanecarboxamide,N-[[5-(5-ethyl-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)-2-furanyl]methyl]-,trifluoroacetate

6,7-DIHYDRO-1-BENZOFURAN-4(5H)-ONE

2-(1H-indazol-4-ylamino)-N-(1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)acetamide

2(1H)-Pyridinone,3-ethyl-5-[5-[[[(2-fluorophenyl)methyl]amino]methyl]-2-thienyl]-6-methyl-,monohydrochloride

methyl 3-amino-4-(methylsulphonyl)thiophene-2-carboxylate

1,3,4-Thiadiazolo[3,2-a]pyridin-4-ium, 2,5,7-triphenyl-, chloride

tetradecanoic acid, compd. with 1-dodecanamine (1:1)

7-Oxa-2-azabicyclo[2.2.1]hept-2-ene, 1-methyl-3-phenyl-5-(4-pyridinyl)-

13125-57-0 msds

CAS No 13125-57-0 supplier

CASNo 13125-57-0 distributor

CAS # 13125-57-0 manufacturer

CAS Number 13125-57-0 safety

CAS RN 13125-57-0 wholesale

2026-10-15 2-Azido-1,3,5-tribromobenzene,CAS No.13125-57-0,Formula:C6H2Br3N3. Find Related Products for Bulk Production or Scientific Research